Track Calithera Biosciences, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Calithera Biosciences, Inc. CALA Open Calithera Biosciences, Inc. in new tab

0.000300 USD
EPS
-3.97
P/B
0.00
ROE
-114.14
Beta
-2.62
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateMay 13, 2026
EPS-3.97
Book Value-0.40
Price to Book0.00
Debt/Equity8.17
Estimates
Forward P/E0.00
Forward EPS-1.35

DCF Valuation

Tweak assumptions to recompute fair value for Calithera Biosciences, Inc. (CALA)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Calithera Biosciences, Inc. Logo Calithera Biosciences, Inc. Analysis (CALA)

United States Health Care Official Website Stock

Is Calithera Biosciences, Inc. a good investment? Calithera Biosciences, Inc. (CALA) is currently trading at 0.000300 USD.

Earnings Schedule: Calithera Biosciences, Inc. is expected to release its next earnings report on May 13, 2026. The market consensus estimate for Forward EPS is -1.35.

Investor FAQ

Does Calithera Biosciences, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Calithera Biosciences, Inc.?

Calithera Biosciences, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be May 13, 2026. The company currently has a trailing EPS of -3.97.

Company Profile

Calithera Biosciences, Inc. operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc. was incorporated in 2010 and is headquartered in South San Francisco, California.

Exchange Ticker
NMS (United States) CALA

Dividends

Historical Split Corporate Actions

Split Date Split Ratio to 1
June 15, 2022 0.050000
Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion